Matthew Emmens (54)
Chief Executive Officer
Matthew Emmens has been Shire's Chief Executive Officer and a member of the Board since March 12, 2003. He began his career in international pharmaceuticals with Merck & Co, Inc. in 1974, where he held a wide range of sales, marketing and administrative positions. In 1992, he helped to establish Astra Merck, a joint venture between Merck and Astra AB of Sweden, becoming President and Chief Executive Officer. In 1999, he joined Merck KGaA and established EMD Pharmaceuticals, the Company's US prescription pharmaceutical business. He was later promoted to President of Merck KGaA's global prescription business, based in Germany. Mr Emmens holds a degree in Business Management from Fairleigh Dickinson University. He is also Chairman of Shire's Executive and Portfolio Review Committees.
|
